The autotransfusion process involves the reinfusion of the patient's blood. Blood is collected from the peritoneal cavity or thorax region. The process can be carried out before surgery or during and after the surgery using the autotransfusion system. Medical procedures, like joint replacement, spinal surgeries, and cardiac, among others, require autotransfusion. It helps to reduce the risk of infection, and also it eliminates the problems and complications associated with the banking and administration of homologous donor blood. It helps to prevent the transmission of transfusion-related blood-borne diseases in patients.

According to our latest study on “Autotransfusion Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Application, and End-User,” and in the global autotransfusion devices market size is expected to grow from US$ 1,000.26 million in 2021 to US$ 1,331.99 million by 2028; it is estimated to grow at a CAGR of 4.2% from 2021 to 2028. The rapid increase in chronic diseases, rise in transplants, and difficulty in obtaining blood groups across the globe are contributing to the autotransfusion devices market growth.

The autotransfusion devices market is majorly comprised of top players such as BD, Braile Biomedica, Fresenius SE & Co. KGaA, Haemonetics Corporation, LivaNova PLC, Medtronic, Redax S.p.A., SARSTEDT AG and Co. KG, Teleflex Incorporated and Zimmer Biomet among others.

Get sample PDF Copy of Autotransfusion Devices Market at @ https://www.theinsightpartners.com/sample/TIPRE00006521/

The report segments the autotransfusion devices market as follows:

·         Based on type,

the autotransfusion devices market is segmented into products and accessories. In 2021, accessories segment held the largest autotransfusion devices market share due to rising demand for technologically advanced products in developed and developing economies including the US, Germany, U.K., France, Japan, and others. Moreover, the rising need of autotransfusion to treat chronic diseases such as cardiovascular diseases, cancer, and traumas is likely to drive the market growth in the forecast period. Moreover, the same segment has the highest CAGR in the anticipated period.

The autotransfusion devices market, by application, is segmented into cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, and others. The cardiac surgeries segment held the largest share of the market in 2021, while the organ transplantation segment is also estimated to register the highest CAGR in the market during the forecast period.

·         By end-user,

the autotransfusion devices market is segmented into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment held largest share of the autotransfusion devices market in 2021, likely to continue its dominance in the market during the forecast period. However, the ambulatory surgical centers segment is anticipated to register the highest CAGR in the autotransfusion devices market during the forecast period.

·         By geography,

the autotransfusion devices market is segmented into North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South & Central America (SCAM). The autotransfusion device market in North America is segmented into the US, Canada, and Mexico. The autotransfusion device market in Europe is segmented into France, Germany, the UK, Spain, Italy, and the Rest of Europe. The autotransfusion device market in Asia Pacific (APAC) is segmented Into China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific. The autotransfusion device market in the Middle East & Africa (MEA) is segmented Into Saudi Arabia, the UAE, South Africa, and the Rest of the Middle East & Africa. The autotransfusion device market in South and Central America (SCAM) is segmented into Brazil, Argentina, and the Rest of South and Central America.

For more details visit here @ https://www.theinsightpartners.com/reports/autotransfusion-systems-market

About Us:                                                                                                                                 

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876